Chloracyzine
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H21ClN2OS |
| Molar mass | 360.90 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Chloracyzine is an antidepressant and coronary vasodilator of the phenothiazine class, invented in Russia and used as an anti-anginal agent.[1] It was found not to have antipsychotic activity, but was instead the first Russian tricyclic drug with antidepressant action.[2]
See also
[edit]References
[edit]- ^ Baum T, Wendt RL, Bergey JL (1977). "Chapter 5: Antiarrhythmic and Antianginal Agents". In Clarke FH (ed.). Annual Reports in Medicinal Chemistry. Vol. 12. Elsevier Science. p. 46. doi:10.1016/S0065-7743(08)61543-2. ISBN 978-0-08-058356-3.
- ^ ДС Данилов (2019). "История трициклических антидепрессантов и ее значение для современной психофармакотерапии" [History of tricyclic antidepressants and its impact on current psychopharmacotherapy]. Социальная и клиническая психиатрия (in Russian).
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |